Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Aerie Pharmaceuticals Inc.
Fiscal year is January-December. All values USD millions. 2011 2012 2013 5-year trend
Sales/Revenue - - 0 0 0
Cost of Goods Sold (COGS) incl. D&A - - 120,000 138,000 64,000
COGS excluding D&A - - 0 0 0
Depreciation & Amortization Expense - - 120,000 138,000 64,000
Depreciation - - 120,000 138,000 64,000
Amortization of Intangibles - - - - 0
Gross Income - - (120,000) (138,000) (64,000)
2011 2012 2013 5-year trend
SG&A Expense - - 14.1M 14.16M 22.11M
Research & Development - - 10.7M 9.27M 11.82M
Other SG&A - - 3.4M 4.88M 10.29M
Other Operating Expense - - 0 0 0
Unusual Expense - - (1.32M) 630,000 6.45M
EBIT after Unusual Expense - - 1.32M (630,000) (6.45M)
Non Operating Income/Expense - - 39,000 20,000 1.27M
Non-Operating Interest Income - - - - 0
Equity in Affiliates (Pretax) - - 0 0 0
Interest Expense - - 109,000 75,000 3.8M
Gross Interest Expense - - 109,000 75,000 3.8M
Interest Capitalized - - 0 0 0
Pretax Income - - (12.97M) (14.98M) (31.15M)
Income Tax - - 0 0 0
Income Tax - Current Domestic - - 0 0 -
Income Tax - Current Foreign - - 0 0 -
Income Tax - Deferred Domestic - - 0 0 -
Income Tax - Deferred Foreign - - 0 0 -
Income Tax Credits - - 0 0 -
Equity in Affiliates - - 0 0 0
Other After Tax Income (Expense) - - (452,000) (665,000) 0
Consolidated Net Income - - (13.42M) (15.64M) (31.15M)
Minority Interest Expense - - 0 0 0
Net Income - - (13.42M) (15.64M) (31.15M)
Extraordinaries & Discontinued Operations - - 0 0 0
Extra Items & Gain/Loss Sale Of Assets - - 0 0 0
Cumulative Effect - Accounting Chg - - 0 0 0
Discontinued Operations - - 0 0 0
Net Income After Extraordinaries - - (13.42M) (15.64M) (31.15M)
Preferred Dividends - - 0 0 450,000
Net Income Available to Common - - (13.42M) (15.64M) (31.6M)
EPS (Basic) - - (2.90) (3.28) (6.38)
Basic Shares Outstanding - - 4.63M 4.77M 4.96M
EPS (Diluted) - - (2.90) (3.28) (6.38)
Diluted Shares Outstanding - - 4.63M 4.77M 4.96M
EBITDA - - (14.1M) (14.16M) (22.11M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.